RxDoctor Payments DataLook up a doctor →

Denis Mee-Lee, MD

Psychiatry · Honolulu, HINPI 1730132416

Payments from drug & device makers

$546,506in general payments, 2019–2025

Across 1,592 payments — averaging $343.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$108K
  • Otsuka America Pharmaceutical, Inc.$107K
  • Neurocrine Biosciences, Inc.$101K
  • Alkermes, Inc.$77K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$72K
  • AbbVie$65K
  • plus $16K from 14 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$546,506 in reported general payments places this provider in the 95th percentile of 183 psychiatry providers in Hawaii.

See all psychiatry providers in Hawaii

Medicare billing

Part B allowed, 2024
$22,500
Medicare patients
32
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →